Migraine Treatment Market Report 2025 – For Visionary Product and Strategy Executives

 For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034.

What is the projected market size of the migraine treatment industry, and what is its expected CAGR?
The migraine treatment market size has grown strongly in recent years. It will grow from $3.18 billion in 2024 to $3.48 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to increased prevalence of migraines, increased healthcare expenditure, improved formulations of existing drugs, expansion of clinical research, development of novel therapies.

The migraine treatment market size is expected to see rapid growth in the next few years. It will grow to $5.32 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to growing awareness and education, emergence of monoclonal antibodies, increasing focus on pediatric migraines, expansion of non-pharmacological interventions, global initiatives for migraine research. Major trends in the forecast period include advancements in therapeutic approaches, wearable devices and digital therapeutics, telemedicine and remote consultations, patient-centric care models, generic drug market growth, oral CGRP inhibitors.

Download Your Free Sample PDF:
Migraine Treatment Market Report 2025

What external factors are influencing the migraine treatment market’s growth momentum?
The prolonged screen exposure is expected to propel the growth of the migraine treatment market. Screen exposure refers to the amount of time individuals spend interacting with electronic screens, such as those on smartphones, tablets, computers, and televisions. Prolonged screen exposure is driven by factors such as increased remote work, online education, digital entertainment, and the growing reliance on technology for social interaction. Migraine treatment manages migraine symptoms triggered or worsened by extended screen time, including medications, lifestyle modifications, and the use of ergonomic practices to minimize strain and prevent attacks. For instance, in May 2024, according to the House of Commons Committee, a UK-based Parliament health agency, in 2021, children's screen time increased by 52% in 2022, with nearly 25% of children and young people showing smartphone usage patterns consistent with behavioral addiction. Therefore, the prolonged screen exposure is driving the growth of the migraine treatment market.

What are the major market segments driving the growth of the migraine treatment industry?
The migraine treatment market covered in this report is segmented –

1) By Types: Episodic, Migraine With Aura, Chronic, Other Types
2) By Treatment: Acute Or Abortive Treatment, Preventive Or prophylactic Treatment, Non-Pharmacological Therapies And Devices
3) By End-User: Hospitals, Clinics, Homecare, Other End-users

Subsegments:
1) By Episodic: Frequent Episodic Migraine, Infrequent Episodic Migraine
2) By Migraine With Aura: Visual Aura, Sensory Aura, Speech Or Language Aura
3) By Chronic: Chronic Migraine Without Aura, Chronic Migraine With Aura
4) By Other Types: Hemiplegic Migraine, Retinal Migraine, Menstrual Migraine, Other Specific Types

View The Full Market Report:
Migraine Treatment Market Report 2025

What future trends will impact the direction of the migraine treatment industry?
Product innovations are the key trend gaining popularity in the migraine treatment market. Major companies operating in the market are introducing innovations such as liquid formulation to sustain their position in the market. For instance, in January 2022, BioDelivery Sciences International (BDSI), a US-based pharmaceutical company, launched Elyxyb (celecoxib oral solution), the acute treatment of migraines in adults, whether or not they experience aura. Its liquid formulation allows for rapid absorption in the small intestine, delivering faster relief compared to traditional tablets. This is especially beneficial for migraine sufferers who experience nausea or vomiting, as it eliminates the need to wait for a pill to dissolve. As the first and only FDA-approved ready-to-use oral solution for migraines, Elyxyb provides a more tolerable and efficient treatment option for managing the sudden, intense pain associated with migraines.

Who are the key market players contributing to the growth of the migraine treatment industry?
Major companies operating in the migraine treatment market are Pfizer Inc., Eli Lilly and Company, Amgen Inc., GlaxoSmithKline PLC, Novartis AG, Bayer AG, Allergan PLC, Abbott Laboratories, Allodynic Therapeutics LLC, AOBiome LLC, AstraZeneca PLC, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Limited, Impel Pharmaceuticals Inc., AbbVie Inc., Alder BioPharmaceuticals Inc., Astellas Pharma Inc., Biohaven Pharmaceutical Holding Company Ltd., Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Endo International PLC, Impax Laboratories Inc., Johnson & Johnson Inc., Lannett Company Inc., Lupin Limited, Merck & Co. Inc., Mylan N.V.

Which regions are leading the growth of the migraine treatment market globally?
North America was the largest region in the migraine treatment market in 2024. The regions covered in the migraine treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Can Companies Use The Migraine Treatment Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.

Purchase The Report And Get A Swift Delivery:
Migraine Treatment Market Report 2025

Need Customized Data On Migraine Treatment Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.

Request Customized Data:
Migraine Treatment Market Report 2025

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

Market Research Reports

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company